enGene Therapeutics Inc. (ENGN) KPIs and segments

ENGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends October 31Also trades as ENGNW

Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 8, 2026Score 3/30

$2.41+0.13 (+5.70%)

Close on Nov 13, 2026Market cap $161.51MP/E –Yield 0.00%

KPIs & segments

Operating metrics and segments that drive enGene Therapeutics's business

Coming soon

This tab will track the numbers specific to enGene Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?